We are proud to introduce Anat Stern, our Chief Operating Officer & Business Development Lead, who brings over 18 years of leadership in healthcare and biotech to the Eliaz Therapeutics mission. 

Anat’s strengths lie in her exceptional combination of deep scientific expertise - holding a MSc & BSc in Biochemistry, and strategic business acumen, supported by an MBA.

Her impart was clearly demonstrated during her 7 year tenure as a CEO of ecoNugenics, Dr. Eliaz's previous venture, which was successfully led through to acquisition. 

Now, leveraging her decade-long partnership with Dr. Eliaz, Anat applies her experience driving growth in complex environments to navigate the path forward for XGal-3® and bring it to patients in need. 

Curious about our operational strategy or have questions for our leadership team? 

Let us know using the #AskETI hashtag!

With gratitude, 

The Eliaz Therapeutics Team